Subscribe

Jeffrey D. Lebensburger, DO

Articles by Jeffrey D. Lebensburger, DO

Sophie M. Lanzkron, MD, MHS

Gene Therapy for Sickle Cell Disease

ByJohn J. Strouse, MD, PhD,Jeffrey D. Lebensburger, DO,Sophie M. Lanzkron, MD, MHS

September 27th 2021

Experts discuss the safety profile and cost of gene therapy for the management of sickle cell disease.

Latest Updated Articles

Trending on CGTlive®

CGTLive®’s Weekly Rewind – December 1, 2025

Around the Helix: Cell and Gene Therapy Company Updates – November 26, 2025

Structuring Partnerships Among Academia, Biotech, and Pharma

© 2025 MJH Life Sciences^®

All rights reserved.